Likewise, a mutation in the Triggering receptor expressed on myeloid cells 2 (TREM2) gene was found to double the risk of AD in two independent case/control samples [8], associated in a family with frontotemporal lobar degeneration [9]. The gene discussed is TREM2; the disease is Alzheimer disease.